Head and Neck Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults who have growths or sores in the mouth and are already scheduled to have surgery or a biopsy in the head and neck area to remove or examine those growths.
- People who have already received previous treatment for their condition may still be considered.
- People who are able to understand and are willing to sign a written consent form agreeing to take part.
Who may not be able to join:
- People who have a known allergy to proflavine or acriflavine (two types of dye-like substances).
- Women who are pregnant or currently breastfeeding.
- People who are already taking part in another clinical trial where they are actively receiving an experimental treatment or agent at the same time as imaging takes place under this study.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ann Gillenwater, M.D. Anderson Cancer Center
Phone: 713-792-8841
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Evaluation of oral mucosa to be used for non-invasive detection and diagnosis with the use of optical imaging after administration of the topical contrast agent proflavine.; Classification of tissue
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.